265 related articles for article (PubMed ID: 17327321)
21. Increased glucose levels are associated with episodic memory in nondiabetic women.
Rolandsson O; Backeström A; Eriksson S; Hallmans G; Nilsson LG
Diabetes; 2008 Feb; 57(2):440-3. PubMed ID: 17977953
[TBL] [Abstract][Full Text] [Related]
22. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.
Stattin P; Palmqvist R; Söderberg S; Biessy C; Ardnor B; Hallmans G; Kaaks R; Olsson T
Oncol Rep; 2003; 10(6):2015-21. PubMed ID: 14534736
[TBL] [Abstract][Full Text] [Related]
23. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study.
Park SM; Lim MK; Jung KW; Shin SA; Yoo KY; Yun YH; Huh BY
J Clin Oncol; 2007 Oct; 25(30):4835-43. PubMed ID: 17947733
[TBL] [Abstract][Full Text] [Related]
24. Socio-economic position at three points in life in association with type 2 diabetes and impaired glucose tolerance in middle-aged Swedish men and women.
Agardh EE; Ahlbom A; Andersson T; Efendic S; Grill V; Hallqvist J; Ostenson CG
Int J Epidemiol; 2007 Feb; 36(1):84-92. PubMed ID: 17510076
[TBL] [Abstract][Full Text] [Related]
25. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
26. [The "Valle Belbo Project" for the prevention of ischemic heart disease: study design and correlations between alcohol and cardiovascular risk factors].
Bertola PL; Stroppiana M; Favro M; Scassa E; Bo S
Ital Heart J Suppl; 2003 Jun; 4(6):495-501. PubMed ID: 19400055
[TBL] [Abstract][Full Text] [Related]
27. Plasma leptin and breast cancer risk: a prospective study in northern Sweden.
Stattin P; Söderberg S; Biessy C; Lenner P; Hallmans G; Kaaks R; Olsson T
Breast Cancer Res Treat; 2004 Aug; 86(3):191-6. PubMed ID: 15567935
[TBL] [Abstract][Full Text] [Related]
28. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
29. Diabetes and risk of endometrial cancer: a population-based prospective cohort study.
Friberg E; Mantzoros CS; Wolk A
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):276-80. PubMed ID: 17301260
[TBL] [Abstract][Full Text] [Related]
30. Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men.
Persson-Moschos ME; Stavenow L; Akesson B; Lindgärde F
Nutr Cancer; 2000; 36(1):19-26. PubMed ID: 10798212
[TBL] [Abstract][Full Text] [Related]
31. Body mass and colorectal cancer risk in the NIH-AARP cohort.
Adams KF; Leitzmann MF; Albanes D; Kipnis V; Mouw T; Hollenbeck A; Schatzkin A
Am J Epidemiol; 2007 Jul; 166(1):36-45. PubMed ID: 17449892
[TBL] [Abstract][Full Text] [Related]
32. Glycemic status and risk of prostate cancer.
Darbinian JA; Ferrara AM; Van Den Eeden SK; Quesenberry CP; Fireman B; Habel LA
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):628-35. PubMed ID: 18349280
[TBL] [Abstract][Full Text] [Related]
33. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
[TBL] [Abstract][Full Text] [Related]
34. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
35. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study.
Söderberg S; Zimmet P; Tuomilehto J; Chitson P; Gareeboo H; Alberti KG; Shaw JE
Int J Obes (Lond); 2007 Jul; 31(7):1126-33. PubMed ID: 17325688
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for renal cell cancer: the multiethnic cohort.
Setiawan VW; Stram DO; Nomura AM; Kolonel LN; Henderson BE
Am J Epidemiol; 2007 Oct; 166(8):932-40. PubMed ID: 17656615
[TBL] [Abstract][Full Text] [Related]
37. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
[TBL] [Abstract][Full Text] [Related]
38. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
Fumeron F; Péan F; Driss F; Balkau B; Tichet J; Marre M; Grandchamp B;
Diabetes Care; 2006 Sep; 29(9):2090-4. PubMed ID: 16936158
[TBL] [Abstract][Full Text] [Related]
39. [Serum gamma-glutamyltransferase levels and the risks of impaired fasting glucose in healthy men: a 2-year follow-up].
Shin JY; Lim JH; Koh DH; Kwon KS; Kim YK; Kim HC; Lee YC; Lee JH; Nam MS; Hong SB; Park SG
J Prev Med Public Health; 2006 Jul; 39(4):353-8. PubMed ID: 16910310
[TBL] [Abstract][Full Text] [Related]
40. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
